ALEXION PHARMACEUTICALS, INC.

Company Description

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH)
Read More on Wikipedia

SEC Filings
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Recent Insider activity

Subsidiaries
EX-21.1
2021-02-08
EX-21.1
2020-02-04
EX-21.1
2019-02-06
EX-21.1
2018-02-08
EX-21.1
2017-02-16
EX-21.1
2017-01-19
EX-21.1
2016-02-08
EX-21.1
2015-02-06
EX-21.1
2014-02-10
EX-21.1
2013-02-19
EX-21.1
2012-02-17
EX-21.1
2011-02-17
Debug Info- Version: 2.6